- Home
- ASIX vs PRTA Comparison
ASIX vs PRTA Comparison
Compare ASIX & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIX
- PRTA
- Stock Information
- Founded
- ASIX 2016
- PRTA 2012
- Country
- ASIX United States
- PRTA Ireland
- Employees
- ASIX N/A
- PRTA N/A
- Industry
- ASIX Major Chemicals
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- ASIX Industrials
- PRTA Health Care
- Exchange
- ASIX Nasdaq
- PRTA Nasdaq
- Market Cap
- ASIX 526.1M
- PRTA 472.1M
- IPO Year
- ASIX N/A
- PRTA N/A
- Fundamental
- Price
- ASIX $14.91
- PRTA $9.93
- Analyst Decision
- ASIX Buy
- PRTA Buy
- Analyst Count
- ASIX 1
- PRTA 9
- Target Price
- ASIX $32.00
- PRTA $16.14
- AVG Volume (30 Days)
- ASIX 272.8K
- PRTA 558.0K
- Earning Date
- ASIX 11-07-2025
- PRTA 11-06-2025
- Dividend Yield
- ASIX 3.50%
- PRTA N/A
- EPS Growth
- ASIX 829.30
- PRTA N/A
- EPS
- ASIX 2.84
- PRTA N/A
- Revenue
- ASIX $1,515,062,000.00
- PRTA $10,341,000.00
- Revenue This Year
- ASIX $4.71
- PRTA N/A
- Revenue Next Year
- ASIX $4.59
- PRTA $672.02
- P/E Ratio
- ASIX $6.43
- PRTA N/A
- Revenue Growth
- ASIX 1.31
- PRTA N/A
- 52 Week Low
- ASIX $17.97
- PRTA $4.32
- 52 Week High
- ASIX $33.00
- PRTA $18.78
- Technical
- Relative Strength Index (RSI)
- ASIX 18.81
- PRTA 48.41
- Support Level
- ASIX $18.20
- PRTA $10.02
- Resistance Level
- ASIX $19.01
- PRTA $11.17
- Average True Range (ATR)
- ASIX 0.76
- PRTA 0.56
- MACD
- ASIX -0.32
- PRTA -0.10
- Stochastic Oscillator
- ASIX 3.17
- PRTA 11.87
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.